Few Older U.S. Adults Using Direct-to-Consumer Health Care Services
By Lori Solomon HealthDay Reporter
TUESDAY, Jan. 23, 2024 -- Only one in 13 older adults has used a direct-to-consumer (DTC) health care service from an online-only provider, according to the results of the latest University of Michigan National Poll on Healthy Aging.
Mark Fendrick, M.D., from the University of Michigan Institute for Healthcare Policy and Innovation in Ann Arbor, and colleagues conducted the survey in July and August 2023 and included 2,657 adults aged 50 to 80 years.
According to the results of the survey, 7.5 percent of participants used at least one DTC health care service from an online-only provider, with higher rates for those 50 to 64 years versus those 65 to 80 years (10 versus 4 percent). Nearly half of those who had used a DTC service said it had been for general health care, while 12 percent said it was for mental health reasons. More than half of DTC users (55 percent) liked the convenience, with a similar percentage reporting that the overall quality of care they received from their primary care provider was better than what they received from a DTC provider. One-third of those who had used a DTC service said their primary care provider was not aware they had done so, even among those receiving a new prescription through the DTC health encounter.
“With rapid growth in this sector of health care predicted for this year and beyond, all providers, insurers, and regulators need to pay more attention to how patients are using these services and why, and the impact on care quality and safety," Fendrick said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.